Keyword: AstraZeneca


Aristea Halts Clinical Trial, Dissolves Company

17.02.2023 -

Safety findings in Phase 2 clinical trials have forced Aristea Therapeutics to stop developing its lead candidate RIST4721 for treating serious immune-mediated...


Amgen-Horizon Deal under Intense Scrutiny

08.02.2023 -

Amgen’s proposed acquisition of Horizon Therapeutics for $28.7 billion, including debt, would be the largest healthcare deal since AstraZeneca’s $39 billion purchase of...


AstraZeneca Buys CinCor Pharma

12.01.2023 -

AstraZeneca has entered into an agreement to buy CinCor Pharma, a US-based clinical-stage biopharma focused on developing novel treatments for resistant and uncontrolled...


AstraZeneca Sells US Site to National Resilience

07.12.2022 -

Two weeks after annnouncing that it would no longer seek to market its Covid-19 vaccine in the US, Anglo-Swedish drugmaker AstraZeneca has unveiled plans to sell its...


UK’s CPI Opens Medicines Manufacturing Innovation Center

05.12.2022 -

The UK’s Center for Process Innovation (CPI) opened its Medicines Manufacturing Innovation Center in Glasgow on Nov. 30, with the aim of accelerating new technologies in...


AstraZeneca Boosts Cancer Portfolio with Neogene Buy

01.12.2022 -

AstraZeneca has agreed to acquire Neogene Therapeutics, a clinical-stage biotechnology company focused on the discovery, development and manufacture of next-generation T...


AstraZeneca Withdraws US Vaxzevria Launch Plan

16.11.2022 -

AstraZeneca (AZ) has announced it is permanently backing away from any plans to sell its Vaxzevria-branded Covid-19 vaccine in the US.


Pharma CEOs Take Action on Climate Change

08.11.2022 -

The CEOs of seven multinational pharmaceutical companies have announced that they are taking joint action to achieve near-term emissions reduction targets and accelerate...